Science

Laura Bukavina: Use of Perioperative Immunotherapy and TKI in RCC with IVC thrombus patients by Kotaro Suzuki et al.

Collage photo of Laura Bukavina and Kotaro Suzuki

Dec 19, 2024, 02:31

Laura Bukavina: Use of Perioperative Immunotherapy and TKI in RCC with IVC thrombus patients by Kotaro Suzuki et al.

A recent paper by Kotaro Suzuki, Postdoctoral Research Fellow at Vancouver Prostate Centre of the University of British Columbia, published in International Journal of Clinical Oncology, was mentioned by Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, on X:

“Use of Perioperative Immunotherapy and TKI in RCC with IVC thrombus patients showed reduction of IVC thrombus level in 47.8% of patients, reduced OR time, EBL mean (3170 mL vs. 1167 mL; p = 0.004) and need for extracorporeal circulation (all Level IV), grade ≥ III perioperative complications (11% vs 0).”

“Impact of presurgical systemic therapy on perioperative outcomes of renal cell carcinoma with inferior vena cava tumor thrombus”

Authors: Kotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, Takuto hara, Tomoaki Terakawa, Yoji Hyodo, Koji Chiba, Akihisa Yao, Jun Teishima, Hideaki Miyake.

More posts featuring Laura Bukavina.

Akihisa Yao cancer Hideaki Miyake Jun Teishima Koji Chiba Kotaro Suzuki Laura Bukavina OncoDaily Oncology RCC renal cell carcinoma Takuto hara Tomoaki Terakawa Yasuyoshi Okamura Yoji Hyodo Yukari Bando

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage